Secretaría de Gobernación
CONACYT
INGER
  2. Repositorio Institucional
  3. 1. Artículos
Mi INGER Alertas Editar perfil
Por favor, use este identificador para citar o enlazar este ítem: http://repositorio.inger.gob.mx/jspui/handle/20.500.12100/17261
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.rights.licensehttp://creativecommons.org/licenses/by/4.0es_MX
dc.creatorADRIAN MARTINEZ RUIZes_MX
dc.creatorPaloma Roa-Rojases_MX
dc.creatorOSCAR ROSAS CARRASCOes_MX
dc.date2018-
dc.date.accessioned2021-10-25T18:30:56Z-
dc.date.available2021-10-25T18:30:56Z-
dc.identifier.urihttp://repositorio.inger.gob.mx/jspui/handle/20.500.12100/17261-
dc.descriptionBackground: Sarcopenia and obesity have a high prevalence in Mexico. Evidence suggests that there is an association between these disorders and clinically significant depressive symptoms. Objective: The aim of the study is to provide the rate and association of depressive symptoms in subjects with sarcopenia and sarcopenic obesity in elderly Mexican. Methods: This study is a cross-sectional analysis of data obtained from the FraDySMex study conducted in Mexico City (n=513). Depressive symptoms were assessed with the short version of the Center for Epidemiological Studies- Depression scale, and a cut-off point ≥ 5 indicated the presence of clinically significant depressive symptoms. A body mass index ≥ 30 defined obesity. Sarcopenia was assessed with the SARC-F questionnaire; a score ≥ 4 indicated the presence of sarcopenia. Sarcopenic obesity was defined as obesity along with sarcopenia. Two models were used to determine the association: one model assessed sarcopenia and depressive symptoms; the other one assessed them with sarcopenic obesity. Results: The analysis included 513 subjects, and the mean age of the subjects was 71.7 ± 9.4; 80.1% were female. The prevalence of CSDS, sarcopenia and sarcopenic obesity was 40.5%, 10% and 7.9%, respectively. Sarcopenia was associated with depressive symptoms (OR 2.64, 95% CI 1.35–5.14, p=0.004), but sarcopenic obesity was not associated with them (OR 1.86, 95% CI 0.89–3.89, p=0.09). Conclusion: Our study found that subjects with only sarcopenia were more likely to have depressive symptoms than subjects with sarcopenic obesity. However, properly prospective studies are needed to better understand this association.es_MX
dc.formatAdobe PDFes_MX
dc.languageenges_MX
dc.publisherInsight Medical Publishinges_MX
dc.relationhttps://clinical-psychiatry.imedpub.com/sarcopenia-but-not-sarcopenic-obesity-is-associated-with-clinically-significant-depressive-symptoms-in-older-mexican-adults.php?aid=22936es_MX
dc.relation.requiresSies_MX
dc.rightsAcceso Abiertoes_MX
dc.sourceClinical Psychiatry (2471-9854) vol. 4 (2018)es_MX
dc.subjectMEDICINA Y CIENCIAS DE LA SALUDes_MX
dc.subjectCiencias médicases_MX
dc.subjectCiencias clínicases_MX
dc.subjectGeriatríaes_MX
dc.subjectBiología y químicaes_MX
dc.subjectSarcopeniaes_MX
dc.subjectDepresiónes_MX
dc.subjectDepressiones_MX
dc.subjectObesidades_MX
dc.subjectObesityes_MX
dc.subjectEnvejecimientoes_MX
dc.subjectAginges_MX
dc.subjectSalud mentales_MX
dc.subjectMental healthes_MX
dc.subjectGeriatríaes_MX
dc.subjectGeriatricses_MX
dc.titleSarcopenia, but not sarcopenic obesity, is associated with clinically significant depressive symptoms in Older Mexican adultses_MX
dc.typeArtículoes_MX
dc.audienceResearcherses_MX
dc.creator.idMARA841109HCHRZD03es_MX
dc.creator.idCA1255787es_MX
dc.creator.idROCO750722HDFSRS05es_MX
dc.creator.nameIdentifiercurpes_MX
dc.creator.nameIdentifiercaes_MX
dc.creator.nameIdentifiercurpes_MX
Aparece en las colecciones: 1. Artículos

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
Clinical Psychiatry (2471-9854) vol. 4 (2018).pdf526.28 kBAdobe PDFVisualizar/Abrir
Mostrar el registro sencillo del ítem